RU2014129620A - Композиции, содержащие аморфный эмодепсид - Google Patents
Композиции, содержащие аморфный эмодепсид Download PDFInfo
- Publication number
- RU2014129620A RU2014129620A RU2014129620A RU2014129620A RU2014129620A RU 2014129620 A RU2014129620 A RU 2014129620A RU 2014129620 A RU2014129620 A RU 2014129620A RU 2014129620 A RU2014129620 A RU 2014129620A RU 2014129620 A RU2014129620 A RU 2014129620A
- Authority
- RU
- Russia
- Prior art keywords
- composition according
- emodepside
- paragraph
- humans
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Abstract
1. Композиция для борьбы с эндопаразитами у человека или животных, содержащая эмодепсид в аморфном состоянии в поливинилпирролидоновой матрице.2. Композиция по пункту 1, дополнительно содержащая поверхностно-активное вещество3. Композиция по пункту 1, отличающаяся тем, что она представляет собой экструдат расплава.4. Композиция по пункту 1, отличающаяся тем, что она представляет собой совместный осадок.5. Лекарственное средство для борьбы с эндопаразитами у человека или животных, содержащее композицию по одному из пп. от 1 до 4, а также фармацевтически приемлемые вспомогательные вещества.
Claims (5)
1. Композиция для борьбы с эндопаразитами у человека или животных, содержащая эмодепсид в аморфном состоянии в поливинилпирролидоновой матрице.
2. Композиция по пункту 1, дополнительно содержащая поверхностно-активное вещество
3. Композиция по пункту 1, отличающаяся тем, что она представляет собой экструдат расплава.
4. Композиция по пункту 1, отличающаяся тем, что она представляет собой совместный осадок.
5. Лекарственное средство для борьбы с эндопаразитами у человека или животных, содержащее композицию по одному из пп. от 1 до 4, а также фармацевтически приемлемые вспомогательные вещества.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11194878.2 | 2011-12-21 | ||
EP11194878 | 2011-12-21 | ||
PCT/EP2012/075909 WO2013092558A1 (de) | 2011-12-21 | 2012-12-18 | Zubereitungen enthaltend amorphes emodepsid |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018105003A Division RU2761529C2 (ru) | 2011-12-21 | 2012-12-18 | Композиции, содержащие аморфный эмодепсид |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2014129620A true RU2014129620A (ru) | 2016-02-10 |
RU2651761C2 RU2651761C2 (ru) | 2018-04-23 |
Family
ID=47358491
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018105003A RU2761529C2 (ru) | 2011-12-21 | 2012-12-18 | Композиции, содержащие аморфный эмодепсид |
RU2014129620A RU2651761C2 (ru) | 2011-12-21 | 2012-12-18 | Композиции, содержащие аморфный эмодепсид |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018105003A RU2761529C2 (ru) | 2011-12-21 | 2012-12-18 | Композиции, содержащие аморфный эмодепсид |
Country Status (24)
Country | Link |
---|---|
US (3) | US9539331B2 (ru) |
EP (1) | EP2793861B1 (ru) |
JP (1) | JP6185930B2 (ru) |
KR (2) | KR101979049B1 (ru) |
CN (2) | CN108187028A (ru) |
AU (2) | AU2012357848C1 (ru) |
BR (1) | BR112014014973A2 (ru) |
CA (1) | CA2859787C (ru) |
CL (1) | CL2014001637A1 (ru) |
CO (1) | CO6990713A2 (ru) |
CR (1) | CR20140293A (ru) |
DO (1) | DOP2014000140A (ru) |
EC (1) | ECSP14005917A (ru) |
ES (1) | ES2734352T3 (ru) |
HK (1) | HK1255536A1 (ru) |
IL (1) | IL233183B (ru) |
MX (2) | MX356094B (ru) |
MY (1) | MY175307A (ru) |
NI (1) | NI201400065A (ru) |
PH (2) | PH12014501438A1 (ru) |
RU (2) | RU2761529C2 (ru) |
UA (1) | UA115232C2 (ru) |
WO (1) | WO2013092558A1 (ru) |
ZA (1) | ZA201404529B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101979049B1 (ko) | 2011-12-21 | 2019-05-15 | 바이엘 파마 악티엔게젤샤프트 | 무정형 에모뎁시드를 함유하는 제제 |
LT3298027T (lt) | 2015-05-20 | 2021-08-10 | Boehringer Ingelheim Animal Health USA Inc. | Antihelmintiniai depsipeptido junginiai |
SG11201805368YA (en) | 2015-12-28 | 2018-07-30 | Merial Inc | Anthelmintic depsipeptide compounds |
WO2018093920A1 (en) | 2016-11-16 | 2018-05-24 | Merial, Inc. | Anthelmintic depsipeptide compounds |
CN114195732A (zh) * | 2022-01-04 | 2022-03-18 | 丽珠集团福州福兴医药有限公司 | 一种艾默德斯的单晶型iii及其制备方法 |
CN115444927B (zh) * | 2022-09-19 | 2023-06-02 | 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) | 艾默德斯在制备治疗三阴性乳腺癌的药物中的应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2874342B2 (ja) | 1992-03-17 | 1999-03-24 | 藤沢薬品工業株式会社 | デプシペプチド誘導体,その製法およびその用途 |
DE19918325A1 (de) * | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
DE10000792A1 (de) * | 2000-01-11 | 2001-07-19 | Bernhard C Lippold | Formulierungen von Wirkstoffen in Form einer festen Dispersion |
DE10031044A1 (de) | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere |
DE10358525A1 (de) * | 2003-12-13 | 2005-07-07 | Bayer Healthcare Ag | Endoparasitizide Mittel zur topischen Applikation |
DE102004055316A1 (de) * | 2004-11-16 | 2006-05-18 | Bayer Healthcare Ag | Verhinderung vertikaler Endoparasiten-Infektionen |
DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
RU2315614C1 (ru) * | 2006-04-19 | 2008-01-27 | Бийтемир Ахмедович Султанбеков | Средство "грепол" и способ применения его при паразитарных заболеваниях |
MX2009007482A (es) * | 2007-02-09 | 2009-08-13 | Pfizer Ltd | Agentes antiparasitarios. |
DE102008022520A1 (de) | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
EP2355802A1 (de) * | 2008-11-14 | 2011-08-17 | Ratiopharm GmbH | Intermediate und orale darreichungsformen enthaltend lenalidomid |
DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
KR101979049B1 (ko) | 2011-12-21 | 2019-05-15 | 바이엘 파마 악티엔게젤샤프트 | 무정형 에모뎁시드를 함유하는 제제 |
-
2012
- 2012-12-18 KR KR1020147017003A patent/KR101979049B1/ko active IP Right Grant
- 2012-12-18 RU RU2018105003A patent/RU2761529C2/ru active
- 2012-12-18 AU AU2012357848A patent/AU2012357848C1/en active Active
- 2012-12-18 CN CN201810220829.0A patent/CN108187028A/zh active Pending
- 2012-12-18 BR BR112014014973A patent/BR112014014973A2/pt not_active Application Discontinuation
- 2012-12-18 UA UAA201408095A patent/UA115232C2/uk unknown
- 2012-12-18 US US14/365,841 patent/US9539331B2/en active Active
- 2012-12-18 ES ES12801761T patent/ES2734352T3/es active Active
- 2012-12-18 EP EP12801761.3A patent/EP2793861B1/de active Active
- 2012-12-18 MX MX2014007224A patent/MX356094B/es active IP Right Grant
- 2012-12-18 WO PCT/EP2012/075909 patent/WO2013092558A1/de active Application Filing
- 2012-12-18 CA CA2859787A patent/CA2859787C/en active Active
- 2012-12-18 RU RU2014129620A patent/RU2651761C2/ru active
- 2012-12-18 JP JP2014547910A patent/JP6185930B2/ja active Active
- 2012-12-18 MY MYPI2014701644A patent/MY175307A/en unknown
- 2012-12-18 MX MX2018002095A patent/MX368209B/es unknown
- 2012-12-18 KR KR1020187019676A patent/KR101978620B1/ko active IP Right Grant
- 2012-12-18 CN CN201280064016.8A patent/CN104023710A/zh active Pending
-
2014
- 2014-06-16 CO CO14129965A patent/CO6990713A2/es unknown
- 2014-06-17 DO DO2014000140A patent/DOP2014000140A/es unknown
- 2014-06-17 IL IL233183A patent/IL233183B/en active IP Right Grant
- 2014-06-19 EC ECIEPI20145917A patent/ECSP14005917A/es unknown
- 2014-06-19 CL CL2014001637A patent/CL2014001637A1/es unknown
- 2014-06-19 CR CR20140293A patent/CR20140293A/es unknown
- 2014-06-20 NI NI201400065A patent/NI201400065A/es unknown
- 2014-06-20 ZA ZA2014/04529A patent/ZA201404529B/en unknown
- 2014-06-20 PH PH12014501438A patent/PH12014501438A1/en unknown
-
2017
- 2017-01-04 US US15/397,923 patent/US20170182118A1/en not_active Abandoned
- 2017-11-03 US US15/803,445 patent/US10251932B2/en active Active
-
2018
- 2018-02-15 PH PH12018500368A patent/PH12018500368A1/en unknown
- 2018-04-04 AU AU2018202376A patent/AU2018202376B2/en active Active
- 2018-08-16 HK HK18110516.4A patent/HK1255536A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502628A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
PH12016500024A1 (en) | Bromodomain inhibitor | |
NZ742220A (en) | Pharmaceutical compositions comprising meloxicam | |
MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
ECSP12011684A (es) | Inhibidores de los virus flaviviridae. | |
RU2014129620A (ru) | Композиции, содержащие аморфный эмодепсид | |
MX339805B (es) | Compuestos organicos. | |
MX2014012374A (es) | Compuestos organicos. | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
MX2014012695A (es) | Derivados de isoindolona. | |
MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
UY33183A (es) | Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento | |
CO6670575A2 (es) | Aminopirazoloqinazolinas sustituidas, útiles en el tratamiento de enfermedades proliferativas y composiciones farmaceúticas que las continen | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
CL2012001836A1 (es) | Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros. | |
DOP2013000243A (es) | Inhibidores sustituidos de acetil-coa carboxilasa | |
MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
CL2016002091A1 (es) | Compuesto de triazina y su uso para fines medicinales | |
EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
MX2015016425A (es) | Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades. | |
PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
CY1113759T1 (el) | Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
CY1122596T1 (el) | Νεες φαρμακοτεχνικες μορφες (τριμεθοξυφαινυλαμινο)πυριμιδινυλιου | |
CL2016000884A1 (es) | Derivados de piperazina y su uso como medicamento. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20181210 |